No study has exactly pinpointed the exact adverse impact of
Covid-19 virus on lymphoma/cancer patients but it is widely accepted that they
are among high-risk groups
Patients suffering
from lymphoma, and having low levels of immunity, are considered among the
groups at high risk of contracting Covid-19,
and even falling prey to the deadly virus, say doctors.
No study has
exactly pinpointed the exact adverse impact of Covid-19 virus on
lymphoma/cancer patients but it is widely accepted that they are among
high-risk groups.
On the eve of World
Lymphoma Awareness Day, the focus is on means to protect those who are at
risk of infections, and its adverse effects, medical experts say.
Patients who
undergo/undergoing cancer treatment have their immune system compromised,
making them more vulnerable to infections, including that of coronavirus. And
those with haematological malignancies such as acute myeloid leukemia (AML), lymphoma,
and myeloma may be particularly vulnerable as these cancers weaken the immune
system.
"Immune
system of an individual weakens when he/she is put through chemotherapy or
immunotherapy or radiation therapy, and increases the risk of patients undergoing
these treatments to get infected with SARS-CoV-2/Covid-19 virus. Even patients
who are not receiving active cancer treatment must stay cautious as the effects
of past therapy are usually long-lasting," said Dr Bhanu Prakash,
Consultant Medical, haemato-oncology, Medicover Hospitals.
No comments:
Post a Comment